We are live on ! Find out more
AIA

Allegis Investment Advisors Portfolio holdings

AUM $326M
1-Year Est. Return 10.36%
This Fund
S&P 500
This Quarter Est. Return
+4.62%
1 Year Est. Return
+10.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$339M
AUM Growth
-$83.5M
Cap. Flow
-$99.4M
Cap. Flow %
-29.31%
Top 10 Hldgs %
30.08%
Holding
293
New
40
Increased
59
Reduced
137
Closed
55
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VFH icon
176
Vanguard Financials ETF
VFH
$13.7B
$328K 0.1%
4,684
-1,169
-20% -$79.2K
XLK icon
177
State Street Technology Select Sector SPDR ETF
XLK
$122B
$325K 0.1%
10,168
-5,000
-33% -$157K
GLD icon
178
SPDR Gold Trust
GLD
$138B
$321K 0.09%
2,598
+119
+5% +$14.4K
VGT icon
179
Vanguard Information Technology ETF
VGT
$147B
$321K 0.09%
15,576
+5,040
+48% +$102K
HD icon
180
Home Depot
HD
$349B
$316K 0.09%
1,665
-593
-26% -$102K
VBK icon
181
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.9B
$300K 0.09%
1,865
-9,382
-83% -$1.47M
PFG icon
182
Principal Financial Group
PFG
$24.7B
$296K 0.09%
4,200
-1,411
-25% -$97.2K
SNPS icon
183
Synopsys
SNPS
$77.7B
$274K 0.08%
3,219
+213
+7% +$18.4K
TSN icon
184
Tyson Foods
TSN
$20.6B
$271K 0.08%
+3,342
New +$256K
GILD icon
185
Gilead Sciences
GILD
$162B
$268K 0.08%
3,740
+206
+6% +$15.6K
EFV icon
186
iShares MSCI EAFE Value ETF
EFV
$29.2B
$264K 0.08%
+4,780
New +$262K
PG icon
187
Procter & Gamble
PG
$342B
$263K 0.08%
2,863
-15,211
-84% -$1.37M
BMY icon
188
Bristol-Myers Squibb
BMY
$131B
$262K 0.08%
4,271
-4,111
-49% -$257K
RPRX
189
DELISTED
Repros Therapeutics Inc.
RPRX
$260K 0.08%
394,206
+165
+0% +$83
HON icon
190
Honeywell
HON
$76.3B
$254K 0.07%
1,830
+38
+2% +$5.1K
SHY icon
191
iShares 1-3 Year Treasury Bond ETF
SHY
$25.1B
$254K 0.07%
3,028
+600
+25% +$50.5K
HYMB icon
192
State Street SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
$3.18B
$251K 0.07%
+9,036
New +$252K
XLV icon
193
State Street Health Care Select Sector SPDR ETF
XLV
$42.4B
$247K 0.07%
2,992
-1,311
-30% -$108K
MRK icon
194
Merck
MRK
$317B
$245K 0.07%
4,570
-4,792
-51% -$266K
MET icon
195
MetLife
MET
$64.3B
$237K 0.07%
+4,680
New +$247K
FNG
196
DELISTED
AdvisorShares New Tech and Media ETF
FNG
$236K 0.07%
+11,000
New +$244K
FMC icon
197
FMC
FMC
$1.32B
$235K 0.07%
+2,868
New +$231K
AES icon
198
AES
AES
$10.5B
$232K 0.07%
21,441
+10,626
+98% +$115K
VKI icon
199
Invesco Advantage Municipal Income Trust II
VKI
$397M
$230K 0.07%
20,192
-36,913
-65% -$420K
PSEC icon
200
Prospect Capital
PSEC
$1.11B
$229K 0.07%
33,984
-3,221
-9% -$21K

Similar funds

Allegis Investment Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Allegis Investment Advisors held 293 positions worth $339M, down 20% from $423M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Allegis Investment Advisors withdrew a net $99.4M in Q4 2017, closing 55 positions and reducing 137 holdings. Its most notable exit was iShares Core MSCI Emerging Markets ETF, an estimated $4.56M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.9% of assets, up from 8.1% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Allegis Investment Advisors opened a new position in State Street SPDR Portfolio S&P 500 Growth ETF worth $17.8M.

  • Allegis Investment Advisors's largest Q4 2017 buy was State Street SPDR Portfolio S&P 500 Growth ETF: 539,846 shares worth $17.8M.
  • Allegis Investment Advisors added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2017, an estimated $3.68M increase.
  • Allegis Investment Advisors's biggest Q4 2017 reduction was Vanguard Morningstar Mega Cap Growth ETF, cutting an estimated $17.5M.
  • Allegis Investment Advisors fully exited iShares Core MSCI Emerging Markets ETF in Q4 2017, selling an estimated $4.56M.
  • Allegis Investment Advisors's ten largest holdings make up 30% of its $339M portfolio in Q4 2017.
  • Allegis Investment Advisors opened 40 new positions and closed 55 in Q4 2017.
  • Allegis Investment Advisors's portfolio value fell 20% quarter-over-quarter to $339M.

Based on Allegis Investment Advisors's 13F filing for Q4 2017, filed 5 Feb 2018.